DE60101370D1 - Pharmazeutische zusammensetzungen, die terbinafin enthalten - Google Patents

Pharmazeutische zusammensetzungen, die terbinafin enthalten

Info

Publication number
DE60101370D1
DE60101370D1 DE60101370T DE60101370T DE60101370D1 DE 60101370 D1 DE60101370 D1 DE 60101370D1 DE 60101370 T DE60101370 T DE 60101370T DE 60101370 T DE60101370 T DE 60101370T DE 60101370 D1 DE60101370 D1 DE 60101370D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
terbinafin
containing terbinafin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60101370T
Other languages
English (en)
Other versions
DE60101370T2 (de
Inventor
Jean-Daniel Bonny
Carl Eugster
Patrice Guitard
Stefan Hirsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60101370D1 publication Critical patent/DE60101370D1/de
Publication of DE60101370T2 publication Critical patent/DE60101370T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60101370T 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten Expired - Lifetime DE60101370T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0001928.1A GB0001928D0 (en) 2000-01-27 2000-01-27 Organic compounds
GB0001928 2000-01-27
PCT/EP2001/000834 WO2001054675A2 (en) 2000-01-27 2001-01-25 Pharmaceutical compositions comprising terbinafine

Publications (2)

Publication Number Publication Date
DE60101370D1 true DE60101370D1 (de) 2004-01-15
DE60101370T2 DE60101370T2 (de) 2004-10-28

Family

ID=9884486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60101370T Expired - Lifetime DE60101370T2 (de) 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten

Country Status (12)

Country Link
US (4) US20090143479A1 (de)
EP (1) EP1250125B1 (de)
JP (1) JP5036114B2 (de)
AT (1) ATE255407T1 (de)
AU (1) AU5211901A (de)
DE (1) DE60101370T2 (de)
DK (1) DK1250125T3 (de)
ES (1) ES2211797T3 (de)
GB (1) GB0001928D0 (de)
PT (1) PT1250125E (de)
TR (1) TR200400314T4 (de)
WO (1) WO2001054675A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515197A (ja) * 2001-12-03 2005-05-26 ドー バイオファーマ インコーポレイテッド 安定化された逆ミセル組成物およびその使用
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
CN101467960B (zh) * 2007-12-29 2012-11-28 浙江康恩贝制药股份有限公司 一种盐酸特比萘芬乳膏及其制备方法
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
KR101623928B1 (ko) * 2015-02-24 2016-05-24 한양대학교 에리카산학협력단 자가나노유화 약물 전달시스템을 이용한 에제티미브의 경구용 고형제제 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694557A (en) * 1970-10-23 1972-09-26 Amazon Natural Drug Co The Anti-inflammation compositions containing taspine or acid salts thereof and method of use
JPS5913717A (ja) * 1982-07-16 1984-01-24 Asahi Chem Ind Co Ltd エマルジヨン製剤
CA1334920C (en) * 1987-06-15 1995-03-28 Michael K. Weibel Use of parenchymal cell cellulose to improve comestibles
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
JPH10338613A (ja) * 1997-06-06 1998-12-22 Pola Chem Ind Inc 透明化粧料
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
WO1999006024A1 (en) * 1997-07-29 1999-02-11 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
US20110086071A1 (en) 2011-04-14
EP1250125A2 (de) 2002-10-23
DK1250125T3 (da) 2004-03-29
WO2001054675A3 (en) 2002-02-14
DE60101370T2 (de) 2004-10-28
JP2003521495A (ja) 2003-07-15
US20090143479A1 (en) 2009-06-04
TR200400314T4 (tr) 2004-03-22
JP5036114B2 (ja) 2012-09-26
US20120244194A1 (en) 2012-09-27
ATE255407T1 (de) 2003-12-15
EP1250125B1 (de) 2003-12-03
WO2001054675A2 (en) 2001-08-02
US20130236514A1 (en) 2013-09-12
AU5211901A (en) 2001-08-07
GB0001928D0 (en) 2000-03-22
ES2211797T3 (es) 2004-07-16
PT1250125E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
UY28348A1 (es) Compuestos novedosos
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
CY1113462T1 (el) Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
HN2001000262A (es) Kit de repinotano
FR2849992B1 (fr) Composition pour une administration par voie orale contenant des capsaicinoides
ATE255407T1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
BRPI0408848A (pt) formulações orais de cladribine
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
SE0001916D0 (sv) Novel formulation
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
CY1106964T1 (el) Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
ECSP034549A (es) Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro
UY27170A1 (es) Formulación de medicamento que contiene un agente agonista muscarínico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN